SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 117 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $898,000 | +12.2% | 81,600 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $800,000 | -9.2% | 81,600 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $881,000 | +5.4% | 81,600 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $836,000 | -26.0% | 81,600 | -5.7% | 0.00% | -50.0% |
| Q2 2016 | $1,130,000 | +22.6% | 86,500 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $922,000 | +38.6% | 86,500 | +19.6% | 0.00% | 0.0% |
| Q4 2015 | $665,000 | +32.5% | 72,300 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $502,000 | -21.7% | 72,300 | +10.7% | 0.00% | -50.0% |
| Q2 2015 | $641,000 | +17.0% | 65,300 | +5.5% | 0.00% | +100.0% |
| Q1 2015 | $548,000 | +1.1% | 61,900 | 0.0% | 0.00% | -50.0% |
| Q4 2014 | $542,000 | +32.8% | 61,900 | +4.6% | 0.00% | 0.0% |
| Q3 2014 | $408,000 | +31.2% | 59,200 | 0.0% | 0.00% | +100.0% |
| Q2 2014 | $311,000 | +15.6% | 59,200 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $269,000 | +2.7% | 59,200 | +14.1% | 0.00% | 0.0% |
| Q4 2013 | $262,000 | -0.4% | 51,900 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $263,000 | +2.3% | 51,900 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $257,000 | – | 51,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|